BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

A new study has found a way to boost the effectiveness of a long-time treatment of a dominant form of bladder cancer. A team ...

A new preclinical study unveils a more powerful and effective immunotherapy for bladder cancer and other solid tumours.BCG ...

The new study maps BCG's broader effects outside the bladder. Previous research had shown that when given as a vaccine, BCG bacteria raise the body's general defenses against a variety of other ...

The team showed that when BCG was administered to mice in their bladders, the bacteria traveled to their bone marrow — and could actually be cultured directly from it.

The team showed that when BCG was administered to mice in their bladders, the bacteria traveled to their bone marrow — and could actually be cultured directly from it. And it is in the bone marrow, ...

While tuberculosis is not a major health issue in New Zealand, worldwide it remains the leading infectious disease killer.  ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

A research team is shedding new light on Bacillus Calmette-Guerin (BCG), a decades-old bladder cancer treatment, which is also given as vaccine against tuberculosis. The findings could help ...